Controversies in Corticosteroid use for Sepsis

Area of Science:

• Critical Care Medicine
• Pharmacology
• Emergency Medicine

Background:

• Severe sepsis and septic shock are life-threatening conditions requiring prompt emergency department management.
• Key treatments include source control, fluid resuscitation, broad-spectrum antimicrobials, and vasopressors.
• The role of corticosteroid therapy in septic shock remains a subject of debate.

Purpose of the Study:

• To critically evaluate the existing evidence regarding corticosteroid administration in patients diagnosed with septic shock.
• To synthesize findings from numerous studies and meta-analyses on this therapeutic intervention.

Main Methods:

• Review of existing literature, including multiple studies and meta-analyses.
• Analysis of data concerning the effects of different corticosteroid dosing strategies (high-dose vs. physiologic-dose).
• Consideration of outcomes such as vasopressor requirements, mortality, and superinfection risk.

Main Results:

• High-dose corticosteroid therapy is linked to increased adverse events.
• Physiologic-dose corticosteroids may reduce the requirement for vasopressors and shorten the duration of shock.
• A definitive mortality benefit from corticosteroid therapy is not consistently demonstrated across studies.
• The risk of superinfection appears low based on the majority of available research.

Conclusions:

• Septic shock carries significant mortality and morbidity, particularly in refractory cases.
• Physiologic-dose corticosteroids are recommended for consideration in vasopressor- and fluid-resistant septic shock, with hydrocortisone as a potential option.
• While potentially reducing vasopressor dependence, corticosteroids currently lack proven mortality benefit in septic shock, necessitating further investigation.